Veracyte H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 South San Francisco, CA HQ🌐 veracyte.com
Does Veracyte sponsor H-1B visas and green cards?
Yes. Veracyte has filed 78 H-1B LCAs and 10 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 Veracyte filed 17 H-1B LCAs at a median base salary of $143,000, about 17% above the national H-1B median of $121,966 for the same period, and 2 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 9 | $146k |
| FY2025 | 8 | $139k |
| FY2024 | 17 | $133k |
| FY2023 | 7 | $140k |
| FY2022 | 2 | $131k |
| FY2021 | 7 | $149k |
| FY2020 | 9 | $101k |
| FY2019 | 9 | $120k |
| FY2018 | 4 | $130k |
| FY2017 | 6 | $105k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 2 | $145k |
| FY2022 | 1 | $121k |
| FY2021 | 3 | $130k |
| FY2020 | 2 | $148k |
| FY2019 | 2 | $104k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 19
- US patents
- Published, not yet granted
- 59
- applications
- Most recent grant
- January 27, 2026
- Top area
- Measuring or testing processes involving enzymes12
Pay against the local market
Veracyte’s 10 most-filed occupations and metros. Its median base salary is 110% of the local BLS median for the same work.
| Occupation | Metro | Filings | Veracyte pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biological Scientists, All Other | San Francisco, CA | 19 | $106,130 | $109,562 | 97% |
| Software Developers | San Francisco, CA | 10 | $136,401 | $150,730 | 90% |
| Accountants and Auditors | San Francisco, CA | 6 | $160,000 | $85,638 | 187% |
| Statisticians | San Francisco, CA | 4 | $110,918 | $138,035 | 80% |
| Software Developers | Seattle, WA | 3 | $155,680 | $167,030 | 93% |
| Biochemists and Biophysicists | San Francisco, CA | 3 | $143,467 | $140,850 | 102% |
| Software Developers | San Diego, CA | 3 | $167,334 | $159,240 | 105% |
| Operations Research Analysts | San Francisco, CA | 3 | $129,221 | $106,177 | 122% |
| Software Quality Assurance Analysts and Testers | San Francisco, CA | 3 | $131,554 | $137,997 | 95% |
| Bioengineers and Biomedical Engineers | San Francisco, CA | 2 | $137,500 | $114,065 | 121% |
About Veracyte
Veracyte is a pharma & biotech company based in South San Francisco, CA. It was founded in 2006. It is listed on Nasdaq as VCYT.
- Name (DOL filings)
- Veracyte
- Listed
- Nasdaq: VCYT
- Incorporated in
- Delaware
- Headquarters
- 6000 Shoreline Court, Suite 300, South San Francisco, CA 94080
- Industry
- Pharma & biotech
- Employees (US, est)
- 608 (2024)
- Revenue FY2025
- $517M +16% from $446M
- Net income FY2025
- $66M +175% from $24M
- R&D FY2025
- $71M (14% of revenue)
Veracyte pays a median H-1B base of $137,332 across FY2017–2026, about 30% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Veracyte
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Twist Bioscience | 108 | 29 | $145k | 6 | 60% |
| Elanco Animal Health | 108 | 61 | $100k | 32 | 40% |
| Personalis | 106 | 12 | $205k | 2 | — |
| Veracyte | 78 | 17 | $143k | 8 | — |
| Vir Biotechnology | 77 | 11 | $180k | 2 | — |
| Planet Pharma | 77 | 16 | $125k | 2 | — |
| Pharmfood Group of Companies | 77 | 3 | $75k | 0 | — |
